SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories gains as its arm to acquire 100% stake in Bombay Ortho

17 Mar 2025 Evaluate

Alkem Laboratories is currently trading at Rs. 4750.00, up by 45.90 points or 0.98% from its previous closing of Rs. 4704.10 on the BSE.

The scrip opened at Rs. 4768.95 and has touched a high and low of Rs. 4829.75 and Rs. 4733.50 respectively. So far 996 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 6440.00 on 17-Sep-2024 and a 52 week low of Rs. 4409.90 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 4829.75 and Rs. 4609.50 respectively. The current market cap of the company is Rs. 56967.94 crore.

The promoters holding in the company stood at 55.66%, while Institutions and Non-Institutions held 28.16% and 16.18% respectively.

Alkem Laboratories’ wholly owned subsidiary -- M/s. Alkem Medtech has executed Share Purchase and Share Subscription Agreement with M/s. Bombay Ortho Industries (Bombay Ortho) to acquire 100% stake in Bombay Ortho.

The proposed investment by Alkem MedTech is a strategic investment which will help to gain manufacturing capabilities to participate in growing orthopedic space and leveraging Bombay Ortho’s expertise within the Hip and Knee implants segment. 

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.

Alkem Laboratories Share Price

5583.70 16.00 (0.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×